Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Patients often experience long-lasting changes to their hair after stem cell transplants.

The document explains various skin conditions and their treatments.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Alternating treatment with two drugs could help cells in a rapid aging disease.

Denosumab treatment for osteoporosis can cause hair loss.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.